ReviewFrontiers in oral health2026
Prospective applications of artificial intelligence for the diagnosis of oral leukoplakia: a scoping review.
Review in Frontiers in oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral leukoplakia (OL) is the most prevalent oral potentially malignant disorder worldwide. Its diagnosis is clinical and based on excluding all other white patches of the oral cavity, which can be challenging and time-consuming. In recent years, artificial intelligence (AI) has emerged as a promising tool to overcome these limitations, yet a comprehensive overview of the existing evidence is still lacking. Objective: This scoping review surveys the current landscape of artificial intelligence applications for diagnosing oral leukoplakia, both clinically and histopathologically. Materials and methods: A comprehensive search was conducted in PubMed, Scopus, Web of Science, and OVID for studies on the use of artificial intelligence for the diagnosis of oral leukoplakia. No date/language restrictions were applied. Two reviewers screened articles and extracted data into predefined tables. Results: Ten studies were included. Early research used spectroscopy-based models, while recent work employed deep learning for clinical and histopathological image analysis. Most models achieved moderate-to-high diagnostic performance, with sensitivity, specificity and accuracy values above 80%. Overall, models allowed differentiating oral leukoplakia from normal oral mucosa, oral squamous cell carcinoma, and proliferative verrucous leukoplakia, with stronger performance in advanced lesions. Furthermore, artificial intelligence showed promise in grading oral epithelial dysplasia severity in histological samples, occasionally outperforming oral pathologists. Conclusions: While current evidence remains preliminary, artificial intelligence shows promise as an adjunct tool for oral leukoplakia diagnosis. However, standardized reporting, inclusion of lesions within datasets, and multicenter validation in large and diverse cohorts are still needed to ensure generalizability and further clinical validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.